{
    "organizations": [],
    "uuid": "fdb7ba86cfe630b15c05c6ba4e91f6705e68cf23",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-shenzhen-kangtai-biologicals-unit/brief-shenzhen-kangtai-biologicals-unit-slovak-republics-imuna-pharm-sign-licence-agreement-idUSL3N1PA2U6",
    "ord_in_thread": 0,
    "title": "BRIEF-Shenzhen Kangtai Biological's Unit, Slovak Republic's Imuna Pharm Sign Licence Agreement",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 15 (Reuters) - Shenzhen Kangtai Biological Products Co Ltd:\n* SAYS ITS UNIT AND SLOVAK REPUBLIC'S IMUNA PHARM A.S. SIGN LICENCE AGREEMENT Source text in Chinese: bit.ly/2DelAgV Further company coverage: (Reporting by Hong Kong newsroom)\n ",
    "published": "2018-01-15T15:51:00.000+02:00",
    "crawled": "2018-01-16T13:22:46.021+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "shenzhen",
        "kangtai",
        "biological",
        "product",
        "co",
        "ltd",
        "say",
        "unit",
        "slovak",
        "republic",
        "imuna",
        "pharm",
        "sign",
        "licence",
        "agreement",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "reporting",
        "hong",
        "kong",
        "newsroom"
    ]
}